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Abstract
 .The carrier protein s responsible for the transport of ceftibuten, a peptide-like dianionic cefem, in rat renal brush-border
membrane were solubilized and purified by a ceftibuten-ligand specific affinity chromatography technique. The proteo-
liposomes reconstituted from the solubilized brush-border membrane proteins by dialysis had Hq-sensitive uptake of
ceftibuten and trans-stimulative effect by cephalexin. A specific uptake activity for ceftibuten was found in the 3.5 M-eluted
fraction but not the flowthrough and the 0.5 M-eluted fraction of the affinity chromatography. Analyzing this active fraction
 .by SDSrPAGE after reconstituting into liposomes gave two major proteins approx. molecular masses of 130 and 107 kDa .
The purification protocol presented in this study permitted an efficient isolation of the carrier proteins responsible for the
transport of ceftibuten and other peptide-like compounds. q 1998 Elsevier Science B.V.
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1. Introduction
Mammalian small intestine and kidney express
transport systems which recognize substrates of en-
w x w xdogenous origin such as glucose 1 , amino acid 2 ,
w xand oligopeptides 3–5 . Molecular cloning studies
have revealed that the Hq-coupling oligopeptide
transporters expressed in the intestine and kidney are
wstructurally different, encoded by different genes 6–
x  .10 . The cloned intestinal peptide transporter PepT1
 .and the kidney transporter PepT2 of human and rat
exhibited only approximate 50% homology in amino
acid sequence. PepT2 consists of 729 amino acids
and is expressed in the kidney and other tissues such
) Corresponding author. Fax: q81 11 756 1505.
as the brain, lung, liver and heart but not in the
intestine, whereas PepT1 is expressed primarily in the
intestine and, to much lesser extent, in the kidney.
The studies made thus far on the transport machinery
of oligopeptides, in spite of being extensive, still fall
short in answering many questions such as: the abso-
lute necessity of the proton gradient as a driving
force; the contradictory results of the gene expression
with those of the physicochemical approaches radia-
w x w xtion inactivation 11 , purification 12 and photo-
w x.affinity labeling 13 aimed at determining the
molecular mass of the transporters; and last but not
least the mechanism by which the transporters are
regulated. On the basis of this introduction, func-
tional purification of the carriers of interest would be
the eventual way for unveiling these obscures. Our
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previous studies by kinetic analysis have indicated
that multiple peptide transport systems are present in
w xthe renal brush-border membrane 14,15 , and more-
over, we could reconstitute the solubilized activity of
ceftibuten transport in the brush-border membrane
w xinto liposomal preparations 16 .
The present study describes an optimal protocol
for the purification of the oligopeptide carrier pro-
teins from rat renal cortex with the use of affinity
chromatography on the immobilized substrate,
ceftibuten.
2. Materials and methods
2.1. Materials
Ceftibuten, cephalexin and compound V, 3-vinyl
w x  .derivative of ceftibuten 17 Fig. 1 were kindly
 .donated by Shionogi Osaka, Japan . Octyl glucoside
 .n-octyl-b-D-glucoside was purchased from Dojindo
 . Kumamoto, Japan . Asolectin L-a-lecithin, com-
.mercial grade type II-S, Sigma, St Louis, USA was
w xcleaned up by the method of Sone et al. 18 before-
 .hand. p-Trifluoromethoxy penylhydrazone FCCP
 .were obtained from Sigma St. Louis, Mo, USA .
 .N-hydroxysuccinamide NHS activated sepharose
column with a spacer arm of six carbon atoms be-
tween N-hydroxysuccinamide group and the matrix
was purchased from Pharmacia HiTrap NHS-
.activated, 5 ml, Uppsala, Sweden . All other chemi-
cals were of reagent grade.
2.2. Isolation of brush-border membrane and solubi-
lization of membrane proteins
 .The brush-border membrane BBM was isolated
from the renal cortex of the male Wistar rat 200–
Fig. 1. The chemical structures of tested compounds.
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. 2q260 g by the Mg rEGTA precipitation method of
w xBiber et al. 19 with several modifications as in our
w xprevious paper 15 . The final pellet was resuspended
in a buffer composed of 100 mM D-mannitol, 100 mM
 .KCl and 20 mM Hepes–Tris pH 7.5 . The protein
concentration was adjusted to 20 mgrml, and the
suspension was stored at y808C under the nitrogen
gas until use. The proteins from renal BBM were
solubilized by suspending 30–40 mg of membrane
proteins in 3 ml of solubilization buffer containing
 .60 mM octyl glucoside, 20 mM Hepes–Tris pH 7.5 ,
100 mM D-mannitol, 100 mM KCl, 10% glycerol,
 .2 mM EDTA, 1 mM dithiothreitol DTT and 0.1 mM
 .phenylmethylsulfonyl fluoride PMSF . After incuba-
tion on ice for 30 min with slow stirring, the super-
natant was obtained from the centrifugation at
100 000=g for 45 min, and used for the liposomal
reconstitution.
Each protein fraction from either the initial solubi-
lization or the affinity chromatography was mixed
with asolectin micellar solution in the solubilization
 .buffer protein:lipids1:20, wrw , and readjusted
the concentration of octyl glucoside to 50 mM. Lipo-
somal reconstitution was achieved by dialysis against
 .a 20 mM Hepes–Tris buffer pH 7.5 containing
0.1 mM EDTA, 2.5 mM MgCl and 0.1 mM DTT for2
36 h at 48C. The proteoliposomes were harvested by
centrifuging the suspension at 100 000=g for 1 h.
The resulted pellet of proteoliposomes was suspended
in a minimal volume of the experimental buffer for
uptake measurement.
2.3. Immobilization of ceftibuten to the NHS-acti˝ated
column
Ceftibuten, the selected ligand, was coupled to the
activated gel according to the instruction of the sup-
plier with minor modifications. Briefly, after washing
the activated gel with three column volumes of 1 mM
HCl at 48C, 5 ml of a 50 mM ceftibuten solution in a
 .carbonate buffer pH 8.3 was injected into the col-
umn. The reaction was run for 2–3 h at room temper-
ature. Then the remaining uncoupled NHS residues
were inactivated by incubating with mo-
noethanolamine. Finally, the column was washed
three times with three column volumes of the carbon-
 .ate buffer and of a 0.1 M acetate buffer pH 4.0
containing 0.5 M NaCl, alternatively. The column
 .was then washed with a phosphate buffer pH 7.0
containing NaN and stored at 48C until use. The3
coupling ratio was found to be approx. 40% as
estimated from the amount of ceftibuten remained in
the washing solution.
2.4. Application onto the ceftibuten-affinity column
The solubilized brush-border membrane protein
solution was 10-fold diluted with 20 mM Mes–NaOH
 .buffer pH 6.0 containing 50 mM NaCl, 1 mM
EDTA, 0.3 mM DTT and 5 mM lactic acid in order to
bring the detergent concentration below its critical
micellar point, and applied onto the affinity column
which was equilibrated in advance with the starting
buffer. The starting buffer had the same composition
of the buffer for dilution, but with the addition of
6.8 mM octyl glucoside. Protein elution was continu-
 .ously monitored by UV absorbance at 280 nm A .280
Following the loading of the membrane proteins, the
column was washed with the starting buffer. When
the A of the eluate reached the value of the280
starting buffer, the ionic strength of the eluent was
step-wisely increased with NaCl. At first, 0.5 M NaCl
removed the weakly bound proteins from the affinity
column, and secondly, the highly bound proteins
were eluted at 3.5 M NaCl. The fractions correspond-
ing to the eluted peaks were collected in ice-cold
tubes and processed for reconstitution, aminopepti-
dase analysis and protein estimation.
2.5. SDS-polyacrylamide gel electrophoresis
SDSrPAGE analysis was performed with an SPG-
1500 Advantec vertical electrophoresis apparatus and
w xthe Laemmli 20 buffer system as described in the
w xprevious report 16 . A precast discontinuous slab gel
 .  .1=140=140 mm containing 10% wrv acryl-
 . Xamide and 0.3% wrv N,N -methylenebisacrylamide
was obtained from Funakoshi Funakoshi, EASY-
.GEL, Tokyo, Japan . Prior to SDSrPAGE the pro-
teins from different membrane preparations were pre-
w xcipitated by the method of Wessel and Flugge 21 as¨
w xmodified by Kramer et al. 12 . The dried protein
precipitates were dissolved in 40–100 ml of a buffer
 .  .containing 50 mM Tris–HCl pH 8.5 , 2% wrv
 .  .SDS, 5% vrv 2-mercaptoethanol, 10% vrv glyc-
 .erol and 0.002% wrv bromophenol blue. The mix-
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Table 1
Purification of the ceftibuten transport activity from rat renal cortex
Step Specific activity Purity Yield
 .  .  .pmolrmg proteinrsec fold %
Reversed phase evaporation technique
Brush-border membrane 12.5 1.0 100.0
n-octyl glucoside extract 4.8 0.38 47.6
3.5 M-eluted fraction on affinity chromatography 15.8 12.7 0.47
Dialysis method
Brush-border membrane 12.5 1.0 100.0
n-octyl glucoside extract 132.6 10.6 48.3
3.5 M-eluted fraction on affinity chromatography 3376.4 270.1 0.42
An aliquot at each step was reconstituted into proteoliposomes and the activity of ceftibuten transport in the presence of an inward Hq
gradient was determined. Final concentration of ceftibuten was 1.0 mM. Each data was expressed by the mean of three or four
measurements.
 .Fig. 2. Trans-stimulation effects of peptide-related compounds on the uptake of ceftibuten at early time period 5 min by proteoliposomes
 .  .reconstituted from the octyl glucoside crude extract. Vesicles 25ml were preloaded with counter-substrate 5 mM at 308C for 1 h.
 .Uptake study was started by incubating the preloaded vesicles with 500 ml of ceftibuten solution 0.312 mM in the absence of
q  .  .H -gradient pH spH s5.5 . Each value is the mean with SEM ns4;5 .in out
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ture was vortexed vigorously and incubated in a
boiling water bath for 5 min. After the separation of
protein at 25 mA, the gel was visualized with
Coomassie-brilliant blue. Molecular-mass determina-
tions were made by using a Sigma Calibration Unit
 .SDS-6H Sigma, St Louis, Mo, USA .
2.6. Uptake experiments
The uptake of ceftibuten into the prepared proteo-
liposomes was performed at 308C by the rapid filtra-
w xtion method as described previously 16 . Unless
specified other wise, uptake was initiated by mixing
40 ml of proteoliposomes with 200 ml of transport
buffer 100 mM D-mannitol, 100 mM KCl and 20 mM
.Mes–Tris, pH 5.5 containing substrates at 308C. The
reaction was stopped with the addition of 4 ml of an
ice-cold stop solution containing 150 mM NaCl and
20 mM Hepes–Tris, pH 7.5. The mixture was rapidly
filtered through a Millipore filter HAWP, 0.45 mm,
.2.5 cm diam. . The filter was then washed 4 ml of the
ice-cold stop solution. Ceftibuten trapped on the filter
was extracted with 300 ml of the stop solution, and
then analyzed by HPLC.
2.7. Analytical procedures
The detection of ceftibuten was carried out by
w xHPLC as described previously 16 . Protein was mea-
w xsured by the method of Lowry et al. 22 with bovine
serum albumin as the standard. Lipid phosphorus was
w xmeasured by the ashing technique of Bartlett 23 .
Aminopeptidase activity was assessed in the eluted
w fractions using the Wako assay kit LAP IC, Osaka,
.Japan . After removing any traces of the peptidase
inhibitor, EDTA by ultrafiltration using a 10 000 kDa
cutoff ultrafilter Millipore, UFP2, LGC24, Tokyo,
.Japan , the resulted aliquot was used for assay of
peptidase activity either directly or after reconstitut-
ing into liposomes according to the routine proce-
dures of reconstitution mentioned above.
Fig. 3. Affinity chromatography of the n-octyl glucoside extract from the renal brush-border membrane for the purification of ceftibuten
 .transport activity. Solubilized proteins octyl glucoside extract were fractionated on a ceftibuten-affinity column as described under
 .Section 2. SDSrPAGE analysis of the eluted fractions 0.5 M and 3.5 M NaCl-eluted fraction were shown in the insets, respectively.
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3. Results
3.1. Reconstitution of H q-cotransport acti˝ity into
the asolectin liposomes
Liposomal preparation by dialysis had an initial
uptake rate of 132.6 pmol ceftibutenrmg protein per
second. These values are approximately 25-fold
greater than those obtained from the freezerthaw
 .technique. Table 1 . To confirm the viability of the
 .carrier protein s responsible for ceftibuten transport,
trans-stimulation study was made as shown in Fig. 2.
In the presence of D-cephalexin and L-valyl-L-proline
inside the vesicles, the uptake was increased 200%
and 150%, respectively. Moreover, compound V and
L-carnosine also enhanced the uptake of ceftibuten
although its stimulative effects were not significantly
different from control value. This result extends the
evidence of the functionality of the reconstituted
 .carrier protein s in the present method.
3.2. Purification of the transport acti˝ity by affinity
chromatography
Fig. 3 shows the elution profile after applying the
solubilized membrane proteins onto the affinity ma-
trix containing ceftibuten coupled via its free amino
Fig. 4. Uptake activity of ceftibuten by proteoliposomes prepared
by the various fractions after eluting from the affinity column.
Uptake study was perform in the presence or absence of an
inward Hq-gradient. Each value represents the mean with SEM
 . )ns5 . P -0.05 significantly different from uptake value in
q  .the presence of an inward H -gradient opened column .
group. Uptake experiments on proteoliposomes re-
constituted from the flowthrough and the 0.5 M
NaCl-eluted fractions revealed that these fractions did
 .Fig. 5. Uptake of ceftibuten 1.0 mM by proteoliposomes reconstituted from the octyl glucoside crude extract or the 3.5 M NaCl-eluted
q fraction of the affinity chromatography. Uptake experiments were performed in the presence of an inward H gradient pH s7.5,in
.  .  .  .  .pH s5.5 with hatched column rwithout opened column FCCP 50 mM . Each value represents the mean with SEM ns4 .out
)) )  .P-0.01, P-0.05 significantly different from control opened column .
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not seem to have a specific uptake activity for
ceftibuten. In contrast, the liposomal reconstitution of
the 3.5 M NaCl-eluted fraction showed a higher up-
take activity in the presence of an inward Hq-gradi-
 .ent Fig. 4 . This uptake activity was able to be
significantly inhibited by the presence of FCCP, a
protonophore, as shown in Fig. 5. Since there is a
possibility that in addition to the oligopeptide trans-
porters, the aminopeptidase which is a membrane
enzyme, might also be able to recognize ceftibuten as
a ligand, the activity of this enzyme was determined
before and after liposomal reconstitution and in the
absence of EDTA. As a result, no activities could be
found in both of the reconstituted and the free pro-
 .teins not shown , indicating that the 3.5 M NaCl-
eluted proteins do not contain aminopeptidase.
3.3. SDSrPAGE analysis
Analyzing the 3.5 M-eluted fraction on the affinity
chromatography by SDSrPAGE before the liposomal
reconstitution gave three proteins with apparent
molecular masses of 129"5, 107"5 and 45"1 kDa
Fig. 6. SDSrPAGE analysis of the highly bound 3.5 M NaCl-
.eluted fraction from the affinity chromatography before and after
reconstitution into liposomes at a lipid-to-protein ratio of 20.
BBM; Brush-border membranes, Reconstituted; proteoliposomes
prepared by 3.5 M-eluted fraction, 3.5 M NaCl; 3.5 M NaCl-eluted
fraction before reconstitution.
Fig. 7. Inhibitory effects of dipeptides and cephalexin on the
 .uptake of ceftibuten 0.5 mM by proteoliposomes prepared from
the 3.5 M NaCl-eluted fraction of affinity chromatography. Up-
take was measured in the presence of an inward Hq-gradient
 .pH s7.5, pH s5.5 . Protein-free liposomes were preparedin out
by the same dialysis method without protein fraction. Inhibitors
were added at a concentration of 10 mM. Each value is the mean
 . ))with SEM ns8;10 . P -0.01, significantly different from
control.
 .Fig. 3 . However, analyzing the same fraction by
SDSrPAGE, after reconstituting into liposomes,
yielded only the former two proteins, indicating an
inability of the 45 kDa protein to be reconstituted into
 .the bilayer of the liposomal membrane Fig. 6 .
3.4. Substrate specificity of the proteoliposomes re-
constituted from the 3.5 M-eluted fraction of the affin-
ity chromatography
The inhibitory effects of dipeptides and cephalexin
were examined in the presence of an inwardly di-
rected proton gradient. As shown in Fig. 7, the
liposomal preparation of this study was characterized
with an inhibition behavior which is similar to that
observed in the native renal brush-border membrane
w xvesicles 14,15 and in the primary proteoliposomes
reconstituted from the total membrane protein solubi-
w xlized 16 . Furthermore, the uptake value of ceftibuten
by the protein-free liposomes was limited and very
close to the uptake values in the presence of in-
hibitors, confirming the functionality of the reconsti-
 .tuted carrier protein s in this preparation.
( )K. Iseki et al.rBiochimica et Biophysica Acta 1368 1998 329–337336
4. Discussion
w xIn our previous study 16 , we have demonstrated a
freezerthaw technique for the reconstitution of the
 .carrier system s responsible for the transport of
ceftibuten and other peptide-related compounds in the
renal brush-border membrane. In the present study,
proteoliposomes were prepared by dialysis method,
and was compared with those prepared by the previ-
w xous method 16 . Finally, proteoliposome reconsti-
tuted by dialysis from 3.5 M-eluted fraction on affin-
ity chromatography had an initial uptake rate of
3.38 nmol ceftibutenrmg protein per second. These
values are approximately 21-fold greater than those
 .obtained from the freezerthaw technique. Table 1 .
Most of the transport characteristics observed in the
w xnative brush-border membrane vesicles 14,15 were
also observed in the reconstituted preparation of the
present study.
w xKramer et al. 13 have mentioned that their at-
tempts to purify the oligopeptide transporter from the
intestinal brush-border membrane with cephalexin
specific affinity chromatography had a slight success,
 .resulting in a tiny amount -1 mg of the putative
 .carrier protein 130 kDa . The success of the protocol
presented in this study could be explained by the
 .following remarks: 1 in contrast to the protocol of
Kramer et al., the detergent concentration of the
membrane preparation was brought down, before ap-
plication onto the column, to a level below the criti-
cal micellar concentration, permitting the carrier pro-
 .teins to restore their functional conformation; 2 in
addition to the fact that ceftibuten has a stronger
affinity to oligopeptide transporter than cephalexin,
ceftibuten was coupled to the affinity matrix via its
free amino group which is not a part of the oligopep-
tide backbone; whereas, this is not the case for
cephalexin which has been linked via its a-amino
 .group; 3 the addition of exogenous lipids to the
solubilized membrane preparation is thought also to
assist in restoring the active form of the transporters.
In the renal brush-border membrane, the presence
of two proteins with the ability to recognize oligopep-
tides has been already assessed by kinetic analysis
w x w x15 , gene expression 24 and photoaffinity labeling
 . w xand target size radiation inactivation techniques 11
using cefadroxil as a substrate. The molecular masses
of these protein determined by target size analysis
 .105 and 130 kDa are in good agreement with the
proteins isolated in the present study. However, the
130-kDa protein is appeared to be a brush-border
binding protein for cephems such as cefadroxil and
ceftibuten because that this protein was photo-
w3 xaffinity-labeled by H cefadroxil even in the ab-
sence of any driving force as described by Boll et al.
w x11 .
Renal brush-border membrane vesicles for peptide
transport studies are normally prepared from the en-
tire portion of the cortical tissue, which contains not
only the proximal convoluted tubule but also the
distal parts of the proximal tubule. Therefore, our
w xprevious results 15 showed that the high-
affinityrlow-capacity as well as the low-
affinityrhigh-capacity peptide transport systems were
detectable in these membrane vesicles. Brandsch et
w xal. 25 demonstrated the presence of the high-affinity
system PepT2 and of the low-affinity system PepT1
in the proximal tubular epithelial cells of the normal
w xkidney. Additionally, Boll et al. 24 isolated a single
 .clone PepT2 , expressing the peptide transport activ-
ity, from cDNA library of rabbit renal cortex, and
reported that in vitro translation of this gene using a
rabbit reticulocyte lysate with canine pancreatic mi-
crosomes yielded translation product with molecular
mass of 107 kDa core protein molecular size of
.83 kDa .
In the present study, the result of affinity chro-
matography showed the proteins with apparent
molecular size of 130- and 107-kDa had affinity for
ceftibuten-ligand. It is speculated that larger protein
is the binding protein as mentioned by Boll et al.
w x11 , and that smaller one is associated with PepT2
transporter although it will be necessary to isolate
and confirm the transport activity of each protein in
the liposomal reconstitution.
On the other hand, the oligopeptide transport sys-
tem in the renal brush-border membrane were re-
ported to be under the regulation of protein kinase C
w xas in the intestinal transport system 26 . Therefore,
the 45 kDa polypeptide found in the highly bound
fraction of affinity chromatography may be a compo-
nent of protein kinase C associated to the carrier
proteins during the purification process, although the
possibility that it is the actin derived from the mem-
brane filament was not excluded.
In conclusion, the purification protocol presented
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in this study permitted an efficient isolation of the
carrier proteins responsible for the transport of
ceftibuten and other peptide-like compounds. The
classification and the physicochemical properties
amino acid sequence, glycosylation, dimensional
.structure, etc. of the isolated protein will be the
subject of further studies.
References
w x  .1 G.W. Gould, G.D. Hollman, Biochem. J. 295 1993 329–
341.
w x2 R.A. Reynold, S.G. Mahoney, P.D. Mcnamara, S. Segel,
 .Biochim. Biophys. Acta 1074 1991 56–61.
w x3 H. Daniel, E.L. Morse, S.A. Adibi, J. Biol. Chem. 267
 .1992 9565–9573.
w x4 C. Tiruppathi, P. Kulanthaivel, V. Ganapathy, F.H. Leibach,
 .Biochem. J. 268 1990 27–33.
w x5 R. Hori, Y. Tomita, T. Katsura, M. Yasuhara, K.-I. Inui, M.
 .  .Takano, Biochem. Pharmacol. 45 9 1993 1763–1768.
w x6 W. Liu, R. Liang, S. Ramamoothy, Y.J. Fei, M.E. Ganapa-
thy, M.A. Hediger, V. Ganapathy, F.H. Leibach, Biochim.
 .Biophys. Acta 1235 1995 461–466.
w x7 M.E. Ganapathy, M. Brandsch, P.D. Prasad, V. Ganapathy,
 .F.H. Leibach, J. Biol. Chem. 270 1995 25672–25677.
w x8 F. Doring, D. Dorn, U. Bachfischer, S. Amasheh, M. Her-¨
 .get, H. Daniel, J. Physiol. 497 1996 773–779.
w x9 M.E. Ganapathy, P.D. Prasad, B. Mackenzie, V. Ganapathy,
 .F.H. Leibach, Biochim. Biophys. Acta 1324 1997 296–308.
w x10 Y.J. Fei, W. Liu, P.D. Prasad, R. Kekuda, T.G. Oblak, V.
 .Ganapathy, F.H. Leibach, Biochemistry 36 1997 452–460.
w x  .11 M. Boll, H. Daniel, Biochim. Biophys. Acta 1233 1995
145–152.
w x12 W. Kramer, F. Girbig, U. Gutjahr, I. Leipe, J. Chromatogr.
 .521 1990 199–210.
w x13 W. Kramer, I. Leipe, E. Petzoldt, F. Girbig, Biochim.
 .Biophys. Acta 939 1988 167–172.
w x14 I. Naasani, M. Sugawara, M. Kobayashi, K. Iseki, K.
 .Miyazaki, Pharm. Res. 12 1995 605–608.
w x15 I. Naasani, K. Sato, K. Iseki, M. Sugawara, M. Kobayashi,
 .K. Miyazaki, Biochim. Biophys. Acta 1231 1995 163–168.
w x16 I. Naasani, T. Kikuchi, M. Sugawara, M. Kobayashi, K.
 .Iseki, K. Miyazaki, Biochim. Biophys. Acta 1283 1996
185–191.
w x17 M. Sugawara, K. Iseki, K. Miyazaki, J. Pharm. Pharmacol.
 .43 1991 433–435.
w x18 N. Sone, M. Yoshida, H. Hirata, Y. Kagawa, J. Biochem. 81
 .1997 519–528.
w x19 J. Biber, B. Steiger, H. Haase, H. Murer, Biochim. Biophys.
 .Acta 647 1981 169–176.
w x  .20 U.K. Laemmli, Nature 227 1970 680–685.
w x  .21 D. Wessel, U.J. Flugge, Anal. Biochem. 138 1984 141–¨
143.
w x22 O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J.
 .Biol. Chem. 193 1951 265–275.
w x  .23 G.R. Bartlett, J. Biol. Chem. 234 1959 466–468.
w x24 M. Boll, M. Herget, M. Wagener, W.H. Weber, D.
Markovich, J. Biber, W. Clauss, H. Murer, H. Daniel, Proc.
 .Natl. Acad. Sci. U.S.A. 93 1996 284–289.
w x25 M. Brandsch, C. Brandsch, P.D. Prasad, V. Ganapathy, U.
 .Hopfer, F.H. Leibach, FASEB J. 9 1995 1489–1496.
w x26 U. Muller, M. Brandsch, P.D. Prasad, Y.J. Fei, V. Ganapa-¨
thy, F.H. Leibach, Biochem. Biophys. Res. Commun. 218
 .  .2 1996 461–465.
